Dysmenorrhea (Menstrual Cramps): The Evidence-Based Supplement Protocol

6 min read ·

Primary dysmenorrhea — the cramping pain at the start of menstruation without underlying pathology — affects roughly half of menstruating people. NSAIDs (ibuprofen, naproxen) and hormonal contraception remain the strongest interventions. Among supplements, four have credible RCT evidence: magnesium, vitamin B1 (thiamine), omega-3, and ginger.

Magnesium, 250–400 mg Daily

A 2001 Cochrane review concluded magnesium reduces dysmenorrhea pain versus placebo, with effect size comparable to ibuprofen in head-to-head trials. The 2017 update reaffirmed positive signal but flagged trial heterogeneity. Take 250 mg of magnesium glycinate daily for 1–2 weeks before menses and through day 3 of bleeding. See our magnesium glycinate piece.

Vitamin B1 (Thiamine), 100 mg Daily

The 1996 Gokhale et al. RCT in 556 adolescent Indian girls with severe dysmenorrhea tested thiamine 100 mg daily for 90 days versus placebo. The intervention arm showed substantial reductions in pain severity — 87% of treated subjects had complete cure or marked improvement versus only 8% in placebo. This is one of the largest effect sizes for any supplement in any condition. Replication in Western populations is limited but the original trial is robust. See thiamine dossier.

EPA-Dominant Omega-3, 1.5–2 g Daily

A 1996 trial in adolescents and a 2012 trial in adults both showed omega-3 supplementation reduced dysmenorrhea pain scores and NSAID use versus placebo. The mechanism likely involves reduced prostaglandin (particularly PGF2α) synthesis. Effect sizes modest but consistent. See our omega-3 form piece.

Ginger (Zingiber officinale), 750–2,000 mg Daily

A 2015 meta-analysis of 7 RCTs concluded ginger powder reduced dysmenorrhea pain comparably to mefenamic acid and ibuprofen. Take 250–500 mg three times daily during the first 3 days of menses. See our ginger piece.

Vitamin E, 200 IU Twice Daily — Five Days Around Menses

A 2005 Iranian RCT in 280 adolescents showed vitamin E 200 IU twice daily for two days before menses and three days during reduced pain intensity versus placebo. Effect smaller than NSAIDs but useful in adolescents who can't tolerate ibuprofen.

What NOT to Take

Avoid evening primrose oil — pooled trial data is null for dysmenorrhea (different from its eczema role). Skip "menstrual support" megaformulas with subclinical doses. Don't replace NSAIDs in severe cases or hormonal contraception when otherwise indicated. Avoid high-dose calcium for dysmenorrhea — the evidence is for PMS, not cramping specifically.

How to Run the Protocol

NSAIDs at first sign of menses or 1 day before (scheduled, not as-needed) remain the most effective acute intervention. Layer magnesium glycinate 250 mg daily ongoing + ginger 250 mg TID during days 1–3 of menses. For adolescents who can't tolerate NSAIDs: thiamine 100 mg daily continuous + magnesium has the strongest pediatric pediatric-adolescent data. If symptoms persist or worsen, gynecology evaluation for endometriosis, fibroids, or adenomyosis. See the related PCOS stack and endometriosis page.

Sources

  1. Pattanittum P, Kunyanone N, Brown J, et al. "Dietary supplements for dysmenorrhoea." Cochrane Database Syst Rev, 2016;3:CD002124. PMID: 27000311. DOI: 10.1002/14651858.CD002124.pub2.
  2. Gokhale LB. "Curative treatment of primary (spasmodic) dysmenorrhoea." Indian Journal of Medical Research, 1996;103:227-231. PMID: 8675234.
  3. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. "Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents." AJOG, 1996;174(4):1335-1338. PMID: 8623866. DOI: 10.1016/s0002-9378(96)70681-6.
  4. Ozgoli G, Goli M, Moattar F. "Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea." Journal of Alternative and Complementary Medicine, 2009;15(2):129-132. PMID: 19216660. DOI: 10.1089/acm.2008.0311.
  5. Ziaei S, Zakeri M, Kazemnejad A. "A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea." BJOG, 2005;112(4):466-469. PMID: 15777446. DOI: 10.1111/j.1471-0528.2004.00495.x.